MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Alemtuzumab to Treat Severe Aplastic Anemia

Phase 2
Completed
Conditions
Severe Aplastic Anemia, Refractory
Severe Aplastic Anemia, Relapse
Interventions
Biological: Alemtuzumab (Campath )
First Posted Date
2005-09-19
Last Posted Date
2020-07-07
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
47
Registration Number
NCT00195624
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Peak Flow Monitoring in Older Adults With Asthma

Not Applicable
Completed
Conditions
Asthma
First Posted Date
2005-09-08
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00149474

Thymic Tolerance in Pediatric Heart Transplantation

Phase 2
Terminated
Conditions
Heart Transplantation
First Posted Date
2005-09-08
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
48
Registration Number
NCT00151164
Locations
🇺🇸

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Effectiveness of the TB Contact Priority Model

Completed
Conditions
Tuberculosis
First Posted Date
2005-09-08
Last Posted Date
2009-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00149448

Does Shared Decision-Making Improve Asthma Outcomes?

Not Applicable
Completed
Conditions
Asthma
First Posted Date
2005-09-08
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00149526

Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns

Not Applicable
Conditions
Cardiovascular Diseases
Heart Diseases
Interventions
Behavioral: Tailored DVDs
First Posted Date
2005-09-02
Last Posted Date
2008-07-30
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
650
Registration Number
NCT00142623
Locations
🇺🇸

Brown University, Providence, Rhode Island, United States

Adherence to Weight Loss for Hypertension in African American Women

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Obesity
First Posted Date
2005-09-02
Last Posted Date
2008-01-21
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00142649

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

Phase 3
Completed
Conditions
Paroxysmal Hemoglobinuria, Nocturnal
First Posted Date
2005-08-12
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
87
Registration Number
NCT00130000
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Exercise Training on Diastolic Heart Function in Postmenopausal Women

Not Applicable
Completed
Conditions
Heart Failure, Congestive
Cardiovascular Diseases
First Posted Date
2005-08-01
Last Posted Date
2006-10-11
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
215
Registration Number
NCT00125476
Locations
🇺🇸

The Cooper Institute, Dallas, Texas, United States

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

Not Applicable
Terminated
Conditions
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Neurologic Manifestations
First Posted Date
2005-07-25
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
334
Registration Number
NCT00123539
Locations
🇺🇸

Washington University, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath